GoldenGolden
BD Biosciences

BD Biosciences

BD Biosciences is a global medical technology company that provides diagnostic and research tools to life scientists, clinical researchers, laboratory professionals, and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.

All edits

Edits on 7 Jun, 2021
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 7 Jun, 2021
Edits made to:
Article (+15/-15 characters)
Article

The three worldwide business segments of BD are BD Medical, BD Diagnostics and BD Biosciences. BD Medical produces medical devicesmedical devices such as needles and syringes, and is the largest manufacturer of medical injection devices in the world. BD Diagnostics provides products for safe collection and transport of diagnostics specimens, instruments and reagents. BD Biosciences produces research and clinical tools related to the analysis of cells including antibodies and diagnostic assays. BD Diagnostics provides products in microbiology for pharmaceutical and medical devices manufacturers, food and beverage producers, personal care products manufacturers, and academic institutions. BD offers traditional and rapid microbiology solutions for bioburden, sterility, objectionable organisms or pathogens, identification and environmental monitoring.

Erin Scherfner"prospector:315:156460"
Erin Scherfner edited on 7 Jun, 2021
Edits made to:
Infobox (+2 properties)
Infobox
Country
United States
Edits on 18 Dec, 2020
Amy Tomlinson Gayle
Amy Tomlinson Gayle edited on 18 Dec, 2020
Edits made to:
Infobox (+2 properties)
Article (+179/-73 characters)
Article

The three worldwide business segments of BD are BD Medical, BD Diagnostics and BD Biosciences.BDBiosciences. BD Medical produces medical devices such as needles and syringes, and is the largest manufacturer of medical injection devices in the world. BD Diagnostics provides products for safe collection and transport of diagnostics specimens, instruments and reagents. BD Biosciences produces research and clinical tools related to the analysis of cells including antibodies and diagnostic assays. BD Diagnostics provides products in microbiology for pharmaceutical and medical devices manufacturers, food and beverage producers, personal care products manufacturers, and academic institutions. BD offers traditional and rapid microbiology solutions for bioburden, sterility, objectionable organisms or pathogens, identification and environmental monitoring.

...

COVID-19 is a respiratory disease caused by the coronavirus strain called SARS-CoV-2, and was declared a global pandemic in March, 2020 and caused by the coronavirus strain called SARS-CoV-2. BD received the European CE mark for its Multitest 6-Color RBNK Reagent with BD Trucount Tubes used to identify and enumerate T-cell subtypes in COVID-19 patients in October, 2020. In the previous 10 years the product has been used to assess immune function in HIV patients. Clinicians use the product to determine percentages and absolute counts of T, B, natural killer cells, and CD4 and CD8 subpopulations of T cells in peripheral blood. In COVID-19, the system can be used to assess how the immune system of a patient is responding to an infection with SARS-CoV-2 coronavirus.

...

BD also produces swabs for COVID-19 testing,; these are COVID-19 rapid molecular diagnostic tests that run on the BD MAX System. andBD also produces other products used in COVID-19 treatment such as infusion pumps, sets, and catheters.

Infobox
Founded date
1897
Edits on 26 Nov, 2020
Meredith Hanel
Meredith Hanel edited on 26 Nov, 2020
Edits made to:
Timeline (+2 events) (+504 characters)
Article (+466/-8 characters)
Further reading (+1 rows) (+3 cells) (+157 characters)
Article

BD Biosciences is a segment of Becton Dickinson, a medical technology company founded in 1897 by Maxwell Becton and Fairleigh Dickinson as Becton, Dickinson and Company. The founders had a vision to improve patient outcomes. BD Biosciences offers products for medical research and clinical laboratories. BD serves customers in life sciences, clinical research and clinicians involved in basic research, drug discovery and development, biopharmaceutical production and disease management. BD Biosciences made significant contributions to HIV research and diagnostics through their instruments for CD4 T cell counting.

...

The three worldwide business segments of BD are BD Medical, BD Diagnostics and BD Biosciences.BD Medical produces medical devices such as needles and syringes. BD Diagnostics provides products for safe collection and transport of diagnostics specimens, instruments and reagents. BD Biosciences produces research and clinical tools related to the analysis of cells including antibodies and diagnostic assays. BD Diagnostics provides products in microbiology for pharmaceutical and medical devices manufacturers, food and beverage producers, personal care products manufacturers and academic institutions. BD offers traditional and rapid microbiology solutions for bioburden, sterility, objectionable organisms or pathogens, identification and environmental monitoring.

...

ClinicalBD Bioscience's clinical instruments include clinical cell analyzers such as flow cytometers and related devices and software for automated laboratory workflow and analysis. Research instruments include cell analyzers, sorters, software, systems for single cell RNA and protein expression analysis and automated research sample prep devices. BD Biosciences markets laboratory reagents and devices with applications in blood collection and cell therapy.

Further reading

Title
Author
Link
Type
Date

BD Biosciences Contributions in CD4 Counting

and Immune Status for HIV/AIDS

Robert A. Hoffman, et al.

Timeline

1991

Establishment of the normal range of lymphocyte subsets for studies of patients with immunodeficiencies

BD Biosciences collaborated with clinical centers to publish a study on the normal range of

lymphocyte subsets, which formed the basis for comparison with studies of patients with immunodeficiencies including AIDS

1974

Becton Dickinson, Inc. licensed Stanford University's FACS technology (fluorescence activated cell sorting) and introduced the first commercial flow cytometer, which was called the FACS-1.
Meredith Hanel
Meredith Hanel edited on 26 Nov, 2020
Edits made to:
Article (+138/-866 characters)
Article

BD Biosciences is a segment of Becton Dickinson, a medical technology company founded in 1897 by Maxwell Becton and Fairleigh Dickinson as Becton, Dickinson and Company. The founders had a vision to improve patient outcomes. BD Biosciences offers products for medical research and clinical laboratories. BD serves customers in life sciences, clinical research and clinicians involved in basic research, drug discovery and development, biopharmaceutical production and disease management.

...

The three worldwide business segments of BD are BD Medical, BD Diagnostics and BD Biosciences. BD Diagnostics provides products in microbiology for pharmaceutical and medical devices manufacturers, food and beverage producers, personal care products manufacturers and academic institutions. BD offers traditional and rapid microbiology solutions for bioburden, sterility, objectionable organisms or pathogens, identification and environmental monitoring.

...

Clinical instruments include clinical cell analyzers such as flow cytometers and related devices and software for automated laboratory workflow and analysis. Research instruments include cell analyzers, sorters, software, systems for single cell RNA and protein expression analysis and automated research sample prep devices. BD Biosciences markets laboratory reagents and devices with applications in blood collection and cell therapy. BD is the largest manufacturer of injection devices in the world. BD’s global manufacturing network produces billions of syringes and needles annually.

...

During the COVID-19 pandemic BD received orders from the US, Canada, the UK and across the world to supply needles and syringes, totaling 330 million as of July 2020, for administration of COVID-19 vaccines. Orders were set to be delivered by the end of 2020 in anticipation to be used for a vaccine expected to be approved late 2020 or early 2021. Expanded needle and syringe production at BD facilities in Nebraska are part of a public-private partnership with BARDA, the Office of the Assistant Secretary for Preparedness and Response (US Health and Human Services) and the Department Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).

Meredith Hanel
Meredith Hanel edited on 26 Nov, 2020
Edits made to:
Timeline (+2 events) (+422/-6 characters)
Timeline

July 6, 2020

Becton Dickinson Wins FDA Approval of 15-Minute, Hand-Held Covid Test

February 13, 2012

Acquisition of KIESTRA Lab Automation BV

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired KIESTRA Lab Automation BV, a Netherlands-based company that designs, develops, manufactures, markets and sells innovative lab automation solutions for the microbiology lab.

1925

The invention was the Luer-lock connector, a secure method of attaching a needle to and removing it from a syringe, which remainremains the standard.

Meredith Hanel
Meredith Hanel edited on 26 Nov, 2020
Edits made to:
Article (+1802/-580 characters)
Article

Products

Clinical instruments include clinical cell analyzers such as flow cytometers and related devices and software for automated laboratory workflow and analysis. Research instruments include cell analyzers, sorters, software, systems for single cell RNA and protein expression analysis and automated research sample prep devices. BD markets laboratory reagents and devices with applications in blood collection and cell therapy. BD is the largest manufacturer of injection devices in the world. BD’s global manufacturing network produces billions of syringes and needles annually.

COVID-19

COVID-19 is a respiratory disease, declared a global pandemic in March, 2020 and caused by the coronavirus strain called SARS-CoV-2. BD received the European CE mark for its Multitest 6-Color RBNK Reagent with BD Trucount Tubes used to identify and enumerate T-cell subtypes in COVID-19 patients in October, 2020. In the previous 10 years the product has been used to assess immune function in HIV patients. Clinicians use the product to determine percentages and absolute counts of T, B, natural killer cells, and CD4 and CD8 subpopulations of T cells in peripheral blood. In COVID-19, the system can be used to assess how the immune system of a patient is responding to an infection with SARS-CoV-2 coronavirus.

...

BD received the European CE mark for its Multitest 6-Color RBNK Reagent with BD Trucount Tubes used to identify and enumerate T-cell subtypes in COVID-19 patients in October, 2020. In the previous 10 years the product has been used to assess immune function in HIV patients. Clinicians use the product to determine percentages and absolute counts of T, B, natural killer cells, and CD4 and CD8 subpopulations of T cells in peripheral blood. In COVID-19, the system can be used to assess how the immune system of a patient is responding to an infection with SARS-CoV-2 coronavirus.

During the COVID-19 pandemic BD received orders from the US, Canada, the UK and across the world to supply needles and syringes, totaling 330 million as of July 2020, for administration of COVID-19 vaccines. Orders were set to be delivered by the end of 2020 in anticipation to be used for a vaccine expected to be approved late 2020 or early 2021. Expanded needle and syringe production at BD facilities in Nebraska are part of a public-private partnership with BARDA, the Office of the Assistant Secretary for Preparedness and Response (US Health and Human Services) and the Department Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).

BD also produces swabs for COVID-19 testing, COVID-19 rapid molecular diagnostic tests that run on the BD MAX System and other products used in COVID-19 treatment such as infusion pumps, sets and catheters.

Edits on 24 Nov, 2020
Meredith Hanel
Meredith Hanel edited on 24 Nov, 2020
Edits made to:
Article (+580 characters)
Article

BD received the European CE mark for its Multitest 6-Color RBNK Reagent with BD Trucount Tubes used to identify and enumerate T-cell subtypes in COVID-19 patients in October, 2020. In the previous 10 years the product has been used to assess immune function in HIV patients. Clinicians use the product to determine percentages and absolute counts of T, B, natural killer cells, and CD4 and CD8 subpopulations of T cells in peripheral blood. In COVID-19, the system can be used to assess how the immune system of a patient is responding to an infection with SARS-CoV-2 coronavirus.

Meredith Hanel
Meredith Hanel edited on 24 Nov, 2020
Edits made to:
Description (+44 characters)
Article (+455/-3 characters)
Topic thumbnail

BD Biosciences

BD Biosciences is a global medical technology company that provides diagnostic and research tools to life scientists, clinical researchers, laboratory professionals, and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.

Article

BD Biosciences wasis a medical technology company founded in 1897 by Maxwell Becton and Fairleigh Dickinson as Becton, Dickinson and Company. The founders had a vision to improve patient outcomes. BD Biosciences offers products for medical research and clinical laboratories. BD serves customers in life sciences, clinical research and clinicians involved in basic research, drug discovery and development, biopharmaceutical production and disease management.

...

Clinical instruments include clinical cell analyzers such as flow cytometers and related devices and software for automated laboratory workflow and analysis. Research instruments include cell analyzers, sorters, software, systems for single cell RNA and protein expression analysis and automated research sample prep devices. BD markets laboratory reagents and devices with applications in blood collection and cell therapy.

Meredith Hanel
Meredith Hanel edited on 24 Nov, 2020
Edits made to:
Infobox (+2 properties)
Timeline (+2 events) (+413 characters)
Description (+8/-40 characters)
Article (+789 characters)
Topic thumbnail

BD Biosciences

BD Biosciences is a world leader in bringing innovativeprovides diagnostic and research tools to life scientists, clinical researchers, laboratory professionals, and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.

Article

BD Biosciences was founded in 1897 by Maxwell Becton and Fairleigh Dickinson as Becton, Dickinson and Company. The founders had a vision to improve patient outcomes. BD Biosciences offers products for medical research and clinical laboratories. BD serves customers in life sciences, clinical research and clinicians involved in basic research, drug discovery and development, biopharmaceutical production and disease management.

...

BD Diagnostics provides products in microbiology for pharmaceutical and medical devices manufacturers, food and beverage producers, personal care products manufacturers and academic institutions. BD offers traditional and rapid microbiology solutions for bioburden, sterility, objectionable organisms or pathogens, identification and environmental monitoring.

Infobox
Founder
Timeline

1954

BD mass-produced disposable syringes for Dr. Jonas Salk's mass vaccination program with the new Salk polio vaccine.

These first disposable syringes, made of glass, were patented by Arthur E. Smith.

1925

BD introduced their Yale Luer-Lok Syringe, designed and patented by Dickinson.

The invention was the Luer-lock connector, a secure method of attaching a needle to and removing it from a syringe, which remain standard.

Edits on 28 Aug, 2020
Melanie Manipula
Melanie Manipula edited on 28 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 18 Aug, 2020
Erin Scherfner"Research engine edit"
Erin Scherfner edited on 18 Aug, 2020
Edits made to:
Infobox (+1 properties)
Edits on 13 Aug, 2020
Aleksander Holm
Aleksander Holm edited on 13 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 5 Mar, 2019
Rebecca Hammond
Rebecca Hammond approved a suggestion from Golden's AI on 5 Mar, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 9 Jan, 2019
Golden AI
Golden AI edited on 9 Jan, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 1 Nov, 2018
Dawson Sewell
Dawson Sewell edited on 1 Nov, 2018
Edits made to:
Infobox (+1 properties)
Description (+290 characters)
Categories (+1 topics)
Topic thumbnail

BD Biosciences

BD Biosciences is a world leader in bringing innovative diagnostic and research tools to life scientists, clinical researchers, laboratory professionals, and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.

Infobox
Categories
Dawson Sewell"Initial topic creation"
Dawson Sewell created this topic on 1 Nov, 2018
Edits made to:
Topic thumbnail

 BD Biosciences

BD Biosciences is a global medical technology company that provides diagnostic and research tools to life scientists, clinical researchers, laboratory professionals, and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.